COVID-19 Resources
IPA recognizes and appreciates the dedication and professionalism of our members who are selflessly serving on the front lines of this public health emergency. From all of us at IPA, thank you for all that you do.
For the latest information, please visit the CDC website or Iowa Board of Pharmacy website.
Iowa Pharmacy Workforce & Volunteers
Trusted Messengers & Vaccine Confidence
Media Resources
COVID-19 Testing
COVID-19 Therapies
COVID-19 Vaccines
Government Activity
Additional Resources
Connecting Over COVID-19
Iowa Pharmacy Workforce & Volunteers
As a pharmacist, pharmacy technician, or student pharmacist, please complete the appropriate sign-up below if you are willing to work temporarily to help another practice site in Iowa. By providing us your information, you agree to have your name, city, and phone number listed on a members-only page for help in the event of an emergency.
If you are not an IPA member, contact ipa@iarx.org for this information.
A message from IPA’s partner, PharmServ Staffing:
“PharmServ Staffing is actively monitoring COVID-19 to determine how we can best support you. Moving forward, until this crisis is over, we will discount our hourly rate for temporary coverage by five percent (5%). You can contact us directly at 515-334-4293 or visit us at www.PharmServstaffing.com.”
- Ready Reserve (USPHS): Part of an elite group of Commissioned Corps, providing trained and ready personnel to fill critical public health needs
- Iowa Statewide Emergency Registry of Volunteers (i-SERV): Part of federal effort to coordinate and assemble volunteers
Trusted Messengers & Vaccine Confidence
IPA has collected resources developed for pharmacists and other health care providers to communicate COVID-19 information to the public:
- The Vaccine Quest: An Online Learning Adventure
- Pharmacists’ Guide to Increasing Equitable Access to COVID-19 Vaccines
- PHCC: Children and COVID-19 Vaccination Toolkit, Talking Points, Answers to Tough Questions
- What is Vaccine Confidence?
- Vaccinate with Confidence COVID-19 Vaccines Strategy for Adults
- Tips for Discussing COVID-19 Vaccines During Patient Visits
- APhA Vaccine Confident
- ASHP Vaccine Confidence Toolkit
- CDC Communication Resources for Healthcare Providers and Staff
IPA offers tips for successful media interviews: If you are interested in being a local contact for media interviews, please contact Allison at ahale@iarx.org.
- APhA: Basics of COVID-19 Testing, Authority to Test, Guide to Testing & CLIA Waiver Process, All Resources
- ASHP: Diagnostic Testing Chart
- CDC: Overview of Testing
- CEimpact COVID-19 Education + Resources, CLIA Waiver Process
- FDA: EUA’s for Medical Devices, Performance of Serology Tests
- HHS Guidance on Pharmacist & COVID-19 Testing (4/8/2020)
- HHS Guidance on Pharmacy Technicians & Interns & Expanded Authorities (10/20/2020)
- Iowa Board of Pharmacy: Process for Reporting Test Results
- Test Iowa
- NIH Treatment Guidelines
- AmeriSourceBergen Direct Order Link
- Bamlanivimab & Etesevimab
- Pause in Distribution (06/25/2021)
- Fact Sheet for Healthcare Providers (5/14/2021)
- Eli Lilly Press Release (2/9/2021)
- Baricitinib (Olumiant)
- Fact Sheet for Healthcare Providers (5/2022)
- FAQ on Olumiant (5/10/2022)
- FDA News Release on Full Approval (5/10/2022)
- Casirivimab & Imdevimab
- FDA Limits Use of REGEN-COV (Casirivimab and Imdevimab) (1/24/2022)
- FDA News Release on EUA for Post-Exposure Prophylaxis (8/10/2021)
- Fact Sheet for Healthcare Providers (5/2021)
- OWS Monoclonal Antibody Playbook (11/23/2020)
- FDA EUA Letter to Regeneron (11/21/2020)
- Convalescent Plasma
- FDA Guidance for Industry (1/2022)
- Fact Sheet for Healthcare Providers (12/28/2021)
- FDA News Release on EUA (2/4/2021)
- Molnupiravir (Lagevrio)
- NIH Guidance (2/24/2022)
- FDA EUA Letter to Merck (12/23/2021)
- Fact Sheets
- Nirmatrelvir/Ritonavir (Paxlovid)
- FDA EUA Letter to Pfizer (7/06/2022)
- FDA Authorizes Pharmacists to Prescribe Paxlovid (7/06/2022)
- NIH Guidance (5/13/2022)
- Remdesivir (Veklury)
- Information for Healthcare Providers (2022)
- FDA News Release on Full Approval (10/22/2020)
- Guidance to Iowa Hospitals from IDPH Remdesivir Advisory Committee (6/26/2020)
- Sotrovimab
- FDA Update to EUA (4/05/2022)
- Fact Sheet for Healthcare Providers (3/2022)
- FDA EUA Letter to GSK (5/26/2021)
- Tocilizumab
Anticoagulation Protocols for COVID-19 Patients:
- NIH Guidelines (5/31/2022)
- UnityPoint Health (4/2020)
- US Pharmacist Summary (4/29/2020)
- Mount Sinai (4/9/2020)
COVID-19 Vaccines
- FDA: COVID-19 Vaccine Information
- CDC: COVID-19 Vaccination Clinical & Professional Resources
- Vaccine Administration Authority
- J&J/Janssen
- Moderna/NIAID
- Novavax
- FDA Letter to Novavax (7/13/2022)
- FDA Information
- Pfizer/BioNTech
- APHA: Patient Flyer – Steps for Getting a COVID-19 Vaccine
- Billing Guidances: Iowa Medicaid, Iowa Total Care, Iowa Total Care, Amerigroup
- CDC:
- CEimpact Immunization Trainings: Pharmacists, Pharmacy Technicians
- COVID-19 Vaccine News: Reuters Tracker
- HHS:
- Guidance on Pharmacists & COVID-19 Vaccines and Immunity under PREP Act (9/3/2020)
- Guidance on Pharmacy Technicians & Interns & Expanded Authorities (10/20/2020)
- IDPH COVID-19 Vaccine Information
- Iowa Provider REDCap Survey
- USP: COVID-19 Vaccine Handling Toolkit
- v-safe After Vaccination Health Checker Website, Print Resources
Federal
- DEA Guidance
- HHS:
- Tools
- Current Emergency Proclamations
- Guidance on Pharmacist & COVID-19 Testing (4/8/2020)
- Guidance on Pharmacists & COVID-19 Vaccines and Immunity under PREP Act (9/3/2020)
- Guidance on Pharmacy Technicians & Interns & Expanded Authorities (10/20/2020)
State
- Board of Pharmacy:
- Governor’s Office Announces Expiration of Public Health Emergency (2/3/2022)
- IDPH PPE Shortage Order
- Regulatory Boards Joint Statement on Hydroxychloroquine and Others (9/11/2020)
- CDC Guidance: Health-Systems (2/2/2022), Nursing Homes & LTC (2/2/2022), Influenza Vaccinations (4/6/2021)
- COVID-19 in Iowa: Summary Statistics, Health Resources, and More
- Project Recovery Iowa: Free Counseling and Assistance for Iowans
- FDA Withdraws Guidance on Temporary Compounding of Hand Sanitizer Products (10/12/2021)
- IPA Guidance on Therapeutic Interchange: Decision Chart, Clinical Guide
- Marketing & Communication Tools: CDC
- National Association General Resource Pages: APhA, ASHP, NCPA, NACDS, ASCP, and SIDP
- Other Community Tools: Curbside Pick-Up Sample
- Other Health-System Tools: ASHP Pharmacy Surge Toolkit, Mount Sinai Resources
- Third Party Payers:
- CMS/Part D Provider Toolkit
- Iowa Medicaid: COVID-19 Information for Providers (7/9/2021)
- Wellmark BCBS
Connecting Over COVID-19
Throughout the pandemic, IPA has hosted free webinars to serve as open forums for addressing immediate COVID-19 questions and concerns. These webinars are scheduled as needed with special guests from the Iowa Board of Pharmacy and other stakeholders. Recordings of previous webinars have been made available.
BACK TO TOP